School of Resources and Environment, Anhui Agricultural University, Hefei, 230036, China.
Biodegradation. 2018 Apr;29(2):129-140. doi: 10.1007/s10532-017-9818-5. Epub 2018 Jan 4.
Because of extensive sulfonamides application in aquaculture and animal husbandry and the consequent increase in sulfonamides discharged into the environment, strategies to remediate sulfonamide-contaminated environments are essential. In this study, the resistance of Shewanella oneidensis MR-1 and Shewanella sp. strain MR-4 to the sulfonamides sulfapyridine (SPY) and sulfamethoxazole (SMX) were determined, and sulfonamides degradation by these strains was assessed. Shewanella oneidensis MR-1 and Shewanella sp. strain MR-4 were resistant to SPY and SMX concentrations as high as 60 mg/L. After incubation for 5 days, 23.91 ± 1.80 and 23.43 ± 2.98% of SPY and 59.88 ± 1.23 and 63.89 ± 3.09% of SMX contained in the medium were degraded by S. oneidensis MR-1 and Shewanella sp. strain MR-4, respectively. The effects of the initial concentration of the sulfonamides and initial pH of the medium on biodegradation, and the degradation of different sulfonamides were assessed. The products were measured by LC-MS; with SPY as a substrate, 2-AP (2-aminopyridine) was the main stable metabolite, and with SMX as a substrate, 3A5MI (3-amino-5-methyl-isoxazole) was the main stable metabolite. The co-occurrence of 2-AP or 3A5MI and 4-aminobenzenesulfonic acid suggests that the initial step in the biodegradation of the two sulfonamides is S-N bond cleavage. These results suggest that S. oneidensis MR-1 and Shewanella sp. strain MR-4 are potential bacterial resources for biodegrading sulfonamides and therefore bioremediation of sulfonamide-polluted environments.
由于磺胺类药物在水产养殖和畜牧业中的广泛应用以及随之而来的磺胺类药物排放量增加到环境中,因此修复受磺胺类药物污染的环境的策略至关重要。在本研究中,测定了希瓦氏菌属 MR-1 和希瓦氏菌属 MR-4 对磺胺吡啶 (SPY) 和磺胺甲恶唑 (SMX) 的磺胺类药物的抗性,并评估了这些菌株对磺胺类药物的降解。希瓦氏菌属 MR-1 和希瓦氏菌属 MR-4 对高达 60 mg/L 的 SPY 和 SMX 浓度具有抗性。孵育 5 天后,MR-1 和 Shewanella sp. strain MR-4 分别降解了培养基中 23.91±1.80%和 23.43±2.98%的 SPY 和 59.88±1.23%和 63.89±3.09%的 SMX。评估了磺胺类药物的初始浓度和培养基初始 pH 值对生物降解的影响,以及不同磺胺类药物的降解情况。通过 LC-MS 测量产物;以 SPY 为底物,2-AP(2-氨基吡啶)是主要的稳定代谢物,以 SMX 为底物,3A5MI(3-氨基-5-甲基异恶唑)是主要的稳定代谢物。2-AP 或 3A5MI 和 4-氨基苯磺酸的共存表明,两种磺胺类药物生物降解的初始步骤是 S-N 键断裂。这些结果表明,希瓦氏菌属 MR-1 和希瓦氏菌属 MR-4 是生物降解磺胺类药物的潜在细菌资源,因此可以用于磺胺类药物污染环境的生物修复。